2001年第345卷03期
共24篇1. Defective urinary concentrating ability due to a complete deficiency of aquaporin-1. 175-9页
作者:L S,King; M,Choi; P C,Fernandez; J P,Cartron; P,Agre
2. Recombinant human activated protein C for severe sepsis. 220; author reply 220-1页
作者:A,Ott; H A,Verbrugh
3. Is it justifiable to withhold treatment for hepatitis C from illicit-drug users? 211-5页
作者:B R,Edlin; K H,Seal; J,Lorvick; A H,Kral; D H,Ciccarone; L D,Moore; B,Lo
4. The treatment of multidrug-resistant tuberculosis in Turkey. 170-4页
作者:K,Tahaoğlu; T,Törün; T,Sevim; G,Ataç; A,Kir; L,Karasulu; I,Ozmen; N,Kapakli
6. Recombinant human activated protein C for severe sepsis. 220; author reply 220-1页
作者:P E,O'Connor
11. The influence of hospital volume on survival after resection for lung cancer. 181-8页
作者:P B,Bach; L D,Cramer; D,Schrag; R J,Downey; S E,Gelfand; C B,Begg
12. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators. 165-9页
作者:G,Agnelli; P,Prandoni; M G,Santamaria; P,Bagatella; A,Iorio; M,Bazzan; M,Moia; G,Guazzaloca; A,Bertoldi; C,Tomasi; G,Scannapieco; W,Ageno; Warfarin Optimal Duration Italian Trial Investigators
13. Pamidronate for bone pain from osteolytic lesions in Langerhans'-cell histiocytosis. 225页
作者:K,Arzoo; S,Sadeghi; V,Pullarkat
14. Appendectomy and protection against ulcerative colitis. 223; author reply 223-4页
作者:A B,Lowenfels; P,Maisonneuve
15. Appendectomy and protection against ulcerative colitis. 223; author reply 223-4页
作者:J L,Frossard; R,de Peyer; A,Hadengue
16. Myocarditis and cardiomyopathy associated with clozapine use in the United States. 224-5页
作者:L,La Grenade; D,Graham; A,Trontell
17. Appendectomy and protection against ulcerative colitis. 222-3; author reply 223-4页
作者:M,Frisch; R J,Biggar
18. Recombinant human activated protein C for severe sepsis. 219; author reply 220-1页
作者:S E,Greisman; C A,Johnston; M S,Gosnell
20. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. 159-64页
作者:H,Meijers-Heijboer; B,van Geel; W L,van Putten; S C,Henzen-Logmans; C,Seynaeve; M B,Menke-Pluymers; C C,Bartels; L C,Verhoog; A M,van den Ouweland; M F,Niermeijer; C T,Brekelmans; J G,Klijn
24. Recombinant human activated protein C for severe sepsis. 219-20; author reply 220-1页
作者:S,Kapur; Y,Kupfer; S,Tessler